|
Inpatient days for all diseases
|
Outpatient days for all diseases
|
Inpatient days for PD
|
Outpatient days for PD
|
---|
|
Coefficient
|
P-value
|
Coefficient
|
P-value
|
Coefficient
|
P-value
|
Coefficient
|
P-value
|
---|
GLMsa
|
−0.94
|
< 0.01
|
0.46
|
< 0.01
|
−0.69
|
< 0.01
|
1.93
|
< 0.01
|
---|
|
Days
|
(SE)
|
Days
|
(SE)
|
Days
|
(SE)
|
Days
|
(SE)
|
---|
Physician visit frequency for PD treatment
|
Lower frequency
|
7.99
|
(0.28)
|
2.35
|
(0.08)
|
3.98
|
(0.22)
|
0.31
|
(0.01)
|
Higher frequency
|
3.13
|
(0.11)
|
3.74
|
(0.10)
|
1.99
|
0.11
|
2.15
|
(0.06)
|
Sex
|
Male
|
5.49
|
(0.21)
|
3.05
|
(0.12)
|
2.88
|
(0.17)
|
1.33
|
(0.05)
|
Female
|
5.46
|
(0.19)
|
3.18
|
(0.08)
|
3.02
|
(0.16)
|
1.31
|
(0.04)
|
Age
|
75–79
|
5.93
|
(0.30)
|
3.19
|
(0.14)
|
3.10
|
(0.25)
|
1.30
|
(0.06)
|
80–84
|
5.45
|
(0.23)
|
3.18
|
(0.10)
|
2.96
|
(0.19)
|
1.37
|
(0.06)
|
85–89
|
5.79
|
(0.27)
|
2.81
|
(0.11)
|
3.27
|
(0.24)
|
1.26
|
(0.06)
|
≥ 90
|
4.23
|
(0.30)
|
3.45
|
(0.27)
|
2.18
|
(0.25)
|
1.36
|
(0.11)
|
Residential facility
|
Home
|
5.94
|
(0.18)
|
3.13
|
(0.08)
|
3.25
|
(0.16)
|
1.30
|
(0.04)
|
Retirement home
|
5.65
|
(0.63)
|
3.34
|
(0.39)
|
2.85
|
(0.52)
|
1.35
|
(0.14)
|
Long-term care facility
|
4.09
|
(0.24)
|
3.05
|
(0.18)
|
2.15
|
(0.19)
|
1.38
|
(0.09)
|
Long-term care level
|
None
|
4.96
|
(0.23)
|
3.26
|
(0.13)
|
2.62
|
(0.18)
|
1.23
|
(0.05)
|
Requiring help
|
6.36
|
(0.46)
|
3.10
|
(0.15)
|
3.81
|
(0.40)
|
1.22
|
(0.07)
|
Long-term care level 1–2
|
5.44
|
(0.28)
|
2.86
|
(0.11)
|
3.09
|
(0.24)
|
1.26
|
(0.06)
|
Long-term care level 3–5
|
5.83
|
(0.29)
|
3.16
|
(0.20)
|
2.96
|
(0.23)
|
1.60
|
(0.10)
|
Mortality
|
No
|
3.90
|
(0.21)
|
3.29
|
(0.12)
|
2.25
|
(0.18)
|
1.27
|
(0.05)
|
Yes
|
6.30
|
(0.20)
|
2.95
|
(0.10)
|
3.30
|
(0.16)
|
1.37
|
(0.06)
|
Malignancy
|
No
|
5.36
|
(0.16)
|
3.00
|
(0.08)
|
3.05
|
(0.14)
|
1.37
|
(0.04)
|
Yes
|
5.76
|
(0.28)
|
3.52
|
(0.14)
|
2.74
|
(0.20)
|
1.19
|
(0.06)
|
Ischemic heart disease
|
No
|
5.15
|
(0.18)
|
2.90
|
(0.09)
|
2.74
|
(0.14)
|
1.24
|
(0.04)
|
Yes
|
5.89
|
(0.22)
|
3.40
|
(0.10)
|
3.25
|
(0.19)
|
1.42
|
(0.06)
|
Cerebrovascular disease
|
No
|
4.62
|
(0.23)
|
3.12
|
(0.15)
|
2.81
|
(0.19)
|
1.28
|
(0.05)
|
Yes
|
5.83
|
(0.17)
|
3.13
|
(0.07)
|
3.02
|
(0.14)
|
1.34
|
(0.04)
|
Dyslipidemia
|
No
|
5.82
|
(0.19)
|
2.93
|
(0.09)
|
3.24
|
(0.16)
|
1.38
|
(0.05)
|
Yes
|
5.02
|
(0.20)
|
3.31
|
(0.11)
|
2.58
|
(0.16)
|
1.26
|
(0.04)
|
Diabetes mellitus
|
No
|
5.49
|
(0.18)
|
2.90
|
(0.08)
|
3.07
|
(0.15)
|
1.27
|
(0.04)
|
Yes
|
5.45
|
(0.21)
|
3.41
|
(0.12)
|
2.80
|
(0.17)
|
1.39
|
(0.06)
|
Dementia
|
No
|
4.55
|
(0.20)
|
3.00
|
(0.09)
|
2.31
|
(0.15)
|
1.19
|
(0.05)
|
Yes
|
6.01
|
(0.19)
|
3.21
|
(0.10)
|
3.35
|
(0.16)
|
1.40
|
(0.05)
|
-
aGLMs only shows the result of physician visit frequency for PD treatment
- Abbreviation: SE Standard error